Barkın Berk

6PUBLICATIONS
16CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 20, 2026
Targeting Inflammatory and Oncogenic Pathways: Cyclooxygenase-2, Epidermal Growth Factor Receptor, and p38 Mitogen-Activated Protein Kinase Inhibition by Pyrazolone Derivatives.

Sevde Nur Biltekin Kaleli, Evren Önay Uçar, Zafer Şahin

|Dec 25, 2023
Synthesis, characterization, COX1/2 inhibition and molecular modeling studies on novel 2-thio-diarylimidazoles.

Zafer Şahin, Melike Koçoğlu Kalkan, Barkın Berk

|Dec 13, 2021
Novel benzofurane-pyrazole derivatives with anti-inflammatory, cyclooxygenase inhibitory and cytotoxicity evaluation.

Zafer Sahin, Yağmur Özhan, Hande Sipahi

|Jul 17, 2020
Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy.

Necdet Uskent, Sule Ayla, Nil Molinas Mandel

|Sep 03, 2019
Potent ribonucleotide reductase inhibitors: Thiazole-containing thiosemicarbazone derivatives.

Merve Ertas, Zafer Sahin, Emre F Bulbul

|Oct 22, 2018
Thiazole-substituted benzoylpiperazine derivatives as acetylcholinesterase inhibitors.

Zafer Sahin, Merve Ertas, Ceysu Bender

Pageof 1

Frequent Collaborators

3 joint publications

Zafer Sahin

3 joint publications

Leyla Yurttas

3 joint publications

Sevde Nur Biltekin Kaleli

3 joint publications

Şeref Demirayak